Major regulatory updates in Vietnam, effective May 2025, cover foreign ownership in finance, fuel price control, statistical reform, and economic classification.
On May 12, 2025, the Trump administration mandated pharmaceutical companies to reduce the prices of drugs sold in the US under the MFN pricing model. This could affect the Indian pharma sector, a key supplier to the US market.
This issue of the BOI Filing in China Q&A series explains how to determine the beneficial owner of an enterprise based on specific circumstances. It is the final installment in this three-part series.
On May 5, 2025, Vietnam introduced Decree No. 97/2025/ND-CP (“Decree 97”), providing incentives for the National Innovation Center (NIC) to create a more favorable environment to foster innovation among the country’s business community.
The UAE luxury market's evolving legal landscape is transforming compliance into a strategic growth tool for luxury brands, offering greater control, protection, and regional expansion opportunities.
China and the US have reached an agreement to reduce reciprocal tariffs from 125% to 10% for 90 days, with the possibility of a broader trade deal on the horizon.
Mark Carney’s pro-trade stance as Canada’s new Prime Minister could open up new trade and business opportunities with China, particularly in clean energy, agriculture, and energy trade.
Despite trade restrictions and cross-border tensions with Pakistan, India’s economy remains resilient—maintaining momentum for domestic manufacturers and continuing to attract foreign investments.